Join the 'Hyperparathyroidism Secondary to Renal Impairment' group to help and get support from people like you.
Hyperparathyroidism Secondary to Renal Impairment Support Group
Our support group for Hyperparathyroidism Secondary to Renal Impairment has 1 questions and 3 members. Updated 17 Aug 2016.
FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis
THOUSAND OAKS, Calif., Feb. 7, 2017 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv (etelcalcetide) for the treatment of ...
Posted 17 Aug 2016 • 1 answerFAQ by Drugs.com